I'm A Patient
I'm A Provider
When a patient receives a dry AMD diagnosis, hearing “we’ll monitor and wait” can feel devastating. People want action, hope, and real solutions, not just supplements and lifestyle changes that won’t improve their vision.
MacuMira can transform your practice from a place of limitation into one of possibility, attracting patients who actively seek the first authorised treatment that can improve visual function in patients with dry AMD.
You Can Finally Offer Real Hope Instead of Just Monitoring
Your patients with dry AMD have lived with frustration for too long. Traditional management may have left them feeling helpless while their vision gradually declined.
Previous approaches focused only on slowing progression through nutritional supplements and lifestyle modifications.
MacuMira changes this dynamic. As the first proven dry AMD treatment that improves visual function, you can now offer genuine hope instead of just prevention. Your patients finally have a reason to feel optimistic about their visual future.
Patients Actively Seek Noninvasive Treatment Options
Today’s patients research their conditions extensively, searching for alternatives to invasive procedures.
MacuMira addresses these concerns:
- It is noninvasive
- Quick 32-minute comfortable sessions in your office
- Zero downtime means immediate return to daily activities
- No adverse effects reported in clinical trials
Your Practice Becomes Their Preferred Destination
Patients travel significant distances to access MacuMira treatment when local eye care professionals don’t offer it. You can become their destination of choice rather than just another appointment on their calendar.
Clinical Results That Build Patient Confidence and Referrals
Strong clinical evidence gives patients confidence in choosing your practice over competitors. When you can point to real data, your patients feel secure in their decision.
The MacuMira clinical results speak for themselves:
- 100% of treated patients showed improved vision in trials
- 48% improved by 10 or more letters on ETDRS chart
- Average 25% increase in visual acuity
- Results are often visible within the first week of treatment
Word-of-Mouth Marketing Works in Your Favour
Satisfied patients become your most powerful advocates. When they experience vision improvements, they naturally share their success stories with family and friends who may also have dry AMD. You can read real patient stories about their experience with the treatment.
You Stand Out as a Forward-Thinking Practice
Being among the first to offer MacuMira positions your practice as innovative and progressive. Patients often perceive practices with modern technology as more capable and comprehensive.
Your early adopter advantage can include:
- Recognition as a leader in dry AMD treatment
- Market advantage before competitors enter the space
- Demonstration of commitment to comprehensive care
MacuMira Attracts New Patient Demographics
This treatment brings new patients to your practice who might not have visited otherwise. You expand your patient base while helping more people preserve their vision.
New patient types include:
- Patients with early-stage dry AMD seeking proactive treatment
- Those who are disappointed with the limited options from other eye care professionals
- Family members of existing patients with AMD
- Patients who are willing to travel for specialised treatment
MacuMira fits seamlessly into your existing workflow without disrupting operations. You receive comprehensive training and ongoing support, making implementation straightforward and efficient.
The treatment protocol creates regular appointment schedules for maintenance care for ongoing patient relationships. Your new MacuMira patients often become long-term patients for all their eye care needs, expanding your practice naturally and sustainably.
Bring Your Patients Hope
Ready to transform your practice and offer your patients the hope they deserve? MacuMira provides the comprehensive support and training you need to successfully integrate this dry age-related macular degeneration treatment into your practice. Contact our team today to learn more about bringing this innovative treatment to your patients.
